Citadel Advisors
LHDX

Citadel Advisors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Citadel Advisors’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-42,800
Closed -$284K – 15012
2021
Q2 		$284K Buy
+42,800
New +$270K ﹤0.01% 11401

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $342M AUM 17.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's LHDX Position: Q1 2022 in Review

Citadel Advisors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2022, closing a stake of 35,544 shares — an estimated $175K sold.

Citadel Advisors first reported a position in LHDX in Q1 2021 and held it in 3 quarters. The position peaked at $391K in Q3 2021. 40 funds tracked by Wall St. Rank hold LHDX as of Q1 2022.

  • Citadel Advisors reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 35,544 Lucira Health, Inc. Common Stock shares in Q1 2022, an estimated $175K.
  • Citadel Advisors first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Citadel Advisors's Lucira Health, Inc. Common Stock position peaked at $391K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.